Literature DB >> 12862038

Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1a.

Maria Rosaria Tola, Luisa Maria Caniatti, Daniela Gragnaniello, Monia Russo, Nevio Stabellini, Enrico Granieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12862038     DOI： 10.1007/s00415-003-1090-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  3 in total

Review 1.  Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis.

Authors:  Babak Soleimani; Katy Murray; David Hunt
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

2.  Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis.

Authors:  Ryuichiro Kumasaka; Norio Nakamura; Kenichi Shirato; Takeshi Fujita; Reiichi Murakami; Michiko Shimada; Masayuki Nakamura; Hiroshi Osawa; Hideaki Yamabe; Ken Okumura
Journal:  Clin Exp Nephrol       Date:  2006-09       Impact factor: 2.801

3.  Thrombotic microangiopathy associated with use of interferon-beta.

Authors:  Teresa Olea; Raquel Díaz-Mancebo; Maria-Luz Picazo; Jorge Martínez-Ara; Angel Robles; Rafael Selgas
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.